Literature DB >> 10817615

Effect of neurokinin-I receptor antagonists on the function of 5-HT and noradrenaline neurons.

N Haddjeri1, P Blier.   

Abstract

Substance P antagonists have been proposed to be a new class of antidepressants. The present study aimed to determine the effect of the selective non-peptide rat neurokinin-1 (NK1) receptor antagonists WIN 51,708 and CP-96,345 on the firing activity of rat dorsal raphe serotonin (5-HT) and locus coeruleus noradrenaline (NA) neurons. While WIN51,708 (2mg/kg, i.v.) and CP-96,345 (0.15 mg/kg, i.v.) did not modify the firing activity of 5-HT and NA neurons, both antagonists attenuated the suppressant effect of the alpha2-adrenoceptor agonist clonidine on the firing activity of both types of neurons. In contrast, the responsiveness of 5-HT neurons to the i.v. administration of the 5-HT autoreceptor agonist LSD and the 5-HT1A receptor agonist 8-OH-DPAT remained unchanged. These findings suggest that NK1 receptor antagonists affect markedly the NA system via an attenuation of the function of alpha2-adrenoceptors on the cell body of NA neurons and, consequently, may also modulate 5-HT neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817615     DOI: 10.1097/00001756-200004270-00035

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  7 in total

Review 1.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline release.

Authors:  Karl Ebner; Nicolas Singewald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-19       Impact factor: 3.000

Review 3.  Trends in the development of new antidepressants. Is there a light at the end of the tunnel?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Med Chem       Date:  2004-04       Impact factor: 4.530

4.  Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response.

Authors:  Pierre Blier; Gabriella Gobbi; Nasser Haddjeri; Luca Santarelli; Gina Mathew; René Hen
Journal:  J Psychiatry Neurosci       Date:  2004-05       Impact factor: 6.186

5.  Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function.

Authors:  L Santarelli; G Gobbi; P C Debs; E T Sibille; P Blier; R Hen; M J Heath
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

6.  Antidepressant-like effects of agomelatine, melatonin and the NK1 receptor antagonist GR205171 in impulsive-related behaviour in rats.

Authors:  Florence Loiseau; Claudine Le Bihan; Michel Hamon; Marie-Hélène Thiébot
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

7.  Synthesis of two potential NK1-receptor ligands using [1-11C]ethyl iodide and [1-11C]propyl iodide and initial PET-imaging.

Authors:  Stina Syvänen; Jonas Eriksson; Tove Genchel; Orjan Lindhe; Gunnar Antoni; Bengt Långström
Journal:  BMC Med Imaging       Date:  2007-07-30       Impact factor: 1.930

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.